The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Latham & Watkins

Work 020 7710 1000
Fax 020 7374 4460

Robbie McLaren

Work +44 20 7710 1880
Latham & Watkins LLP

Work Department



Robbie McLaren is a partner in the London office of Latham & Watkins and has previously worked in the firm's Moscow office. His practice focuses primarily on mergers and acquisitions, private equity, venture capital, reorganizations and general corporate matters.

In recent years, Mr. McLaren has represented clients who operate in a number of industries, with a particular focus on clients in the life sciences, healthcare, and mining and metals industries.

London: Corporate and commercial

M&A: upper mid-market and premium deals, £500m+

Within: M&A: upper mid-market and premium deals, £500m+

Latham & Watkins handles corporate, transactional and advisory work for corporates, private equity sponsors, funds and investment banks. The US-firm acts for a large number of multi-jurisdictional clients, with a particular focus on the US-UK pipeline, advising on both inbound and outbound investment. The firm frequently acts opposite Magic Circle and Silver Circle firms, as was the case when advising JP Morgan as financial sponsor to Takeda Pharmaceuticals on its acquisition of Shire. The matter was led by Richard Butterwick, who also advised GVC Holdings in connection with the acquisition of Ladbrokes Coral. Farah O’Brien specialises in cross-border private M&A, and has a strong track record in joint ventures and corporate restructurings. The 'oustanding' Ed Barnett has extensive experience advising international companies on cross-border M&A transactions, and works with a number of high-profile clients across key sectors. The practice is led by Nick Cline and Robbie McLaren, and benefited from the arrivals of Brendan Moylan from Clifford Chance LLP and Neil Ferguson from Jones Day, specialists in infrastructure and real estate transactions respectively.

[back to top]

London: TMT (technology, media and telecoms)

Pharmaceuticals and biotechnology

Within: Pharmaceuticals and biotechnology

Latham & Watkins serves life sciences companies ranging from big pharma to small bio-techs and also counts funds investing in the sector among its clients. It also offers the advantage of a global network. It is largely focused on transactional work and corporate partner Robbie McLaren handles areas such as cross-border acquisitions, and capital raisings. Fellow co-head Gail E Crawford handles cases on the tech side and includes all aspects of data privacy as a specialism. Edward Barnett deals with M&A transactions, commercial and governance matters and includes GlaxoSmithKline as a client. Frances Stocks Allen and Emily Cridland are noted associates in the team.

[back to top]

Back to index

Legal Developments in London

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to